ESR1 and breast cancer: For example, the well-defined 2013 St Gallen subtypes of breast cancer were based on the expressions of estrogen (ER) and progesterone (PR) receptors, human epidermal growth factor receptor 2 (HER2), and Ki67 proliferative index, which provide prognostic information and can be used to tailor systemic adjuvant therapy (2).